BRIAN FELDMAN: Open Payments
NPI 1336243716 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 25 payments from 9 companies in 2025. Trend: 2023 $500 · 2024 $619 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $143 |
| Vanda Pharmaceuticals Inc. | 5 | $136 |
| Alkermes, Inc. | 4 | $99 |
| Bausch Health US, LLC | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: INGREZZA, HETLIOZ, LYBALVI, APLENZIN, TRINTELLIX, CAPLYTA, FANAPT, Auvelity.
Industry payments across FL — which companies pay providers there.
